Brain organoids, also known as cerebral organoids or mini-brains, are 3D cellular models grown from stem cells that mimic the architecture and function of the human brain. They offer an unprecedented opportunity to study brain development, disease mechanisms, and therapeutic testing in a controlled environment.

The Brain Organoids session explores how stem-cell-derived neural tissues are revolutionizing neuroscience research. These organoids replicate the structural complexity of brain regions, allowing researchers to observe neuronal differentiation, connectivity, and disease modeling.

Presentations at the Brain Organoids Conference highlight the integration of genetics, bioengineering, and single-cell transcriptomics in organoid development. Scientists are using these models to study disorders like autism, epilepsy, and Alzheimer’s disease, as well as to test neurotoxic compounds safely.

Attendees will discover how organoids bridge laboratory and clinical neuroscience by enabling drug screening, modeling infections, and studying early human neurodevelopment. This field is also advancing ethical discussions about the limits of consciousness and sentience in artificial brain systems.

Groundbreaking studies in Cellular Neurobiology continue to enhance the realism and translational potential of brain organoids in personalized medicine.